Pancreatic cancer tends to be highly resistant to current therapy and remains one of the great challenges in biomedicine with very low 5-year survival rates. Here, we report that zalcitabine, an antiviral drug for human immunodeficiency virus infection, can suppress the growth of primary and immorta...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!